| Effects of Targeted Lower Extremity Joint Training on Multiple Sclerosis (MS) Gait Abnormalities (NCT00906737) | Mount Sinai Rehabilitation Hospital | 2009-04-01 |
| Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment (NCT00881205) | Novartis Pharmaceuticals | 2009-04-01 |
| Chronotherapy in Acute Multiple Sclerosis (MS) Attack (NCT00764413) | Sykehuset Innlandet HF | 2009-04-01 |
| A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis (NCT00883337) | Sanofi | 2009-04-01 |
| Expiratory Muscle Training for Persons With Neurodegenerative Disease (NCT00856518) | VA Office of Research and Development | 2009-03-01 |
| The Effectiveness of Locomotor Therapy Using Robot-Driven Gait Orthosis System in Multiple Sclerosis Patients (NCT00843128) | Hadassah Medical Organization | 2009-03-01 |
| Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b (NCT03408093) | Bayer | 2009-02-03 |
| Longitudinal (Weekly) Follow-up of Active Plaques in Multiple Sclerosis With 3 Teslas Multi-modality MRI Using Diffusion, Perfusion, Venography and Proton Spectroscopy (NCT00861172) | Hospices Civils de Lyon | 2009-02-01 |
| Low Fat Diet and Multiple Sclerosis (NCT00852722) | Oregon Health and Science University | 2009-02-01 |
| Safety of Polyphenon E in Multiple Sclerosis Pilot Study (NCT00836719) | Louisiana State University Health Sciences Center in New Orleans | 2009-02-01 |
| Effects of Meditation on Multiple Sclerosis and Peripheral Neuropathy (NCT00981643) | The Cleveland Clinic | 2009-02-01 |
| Assessment of Subject Use of the Rebiject II Injection Device According to Nurse Examination of Subject Accuracy in 10 Steps as a Dummy Demonstration (NCT01195857) | Merck KGaA, Darmstadt, Germany | 2009-01-01 |
| Trial of Ginkgo as a Treatment for Cognitive Problems in Multiple Sclerosis (NCT00841321) | US Department of Veterans Affairs | 2009-01-01 |
| Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects (NCT00828204) | Biogen | 2009-01-01 |
| Evaluation of the Positron Emission Tomography (PET) Tracer ZK 6032924 in Patients With Multiple Sclerosis Compared to Healthy Volunteers (NCT01031199) | Bayer | 2009-01-01 |
| Re-training to Effort (RE) According to the Severity of Multiple Sclerosis: Preliminary Assessments Based on Fatigue and Quality of Life (NCT02848976) | Nantes University Hospital | 2009-01-01 |
| Oral Cladribine in Early Multiple Sclerosis (MS) (NCT00725985) | EMD Serono Research & Development Institute, Inc. | 2008-12-31 |
| Therapy Optimization in Multiple Sclerosis (MS) (NCT00819000) | Teva Neuroscience, Inc. | 2008-12-01 |
| Regional Cortical Cerebral Quantitative MRI Perfusion Correlation Neurocognition in Multiple Sclerosis (NCT00812474) | Sunnybrook Health Sciences Centre | 2008-12-01 |
| Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis (NCT00811902) | Sanofi | 2008-12-01 |
| Magnetic Resonance Imaging (MRI) Follow-up of Macrophagic Infiltration in MS Patients Treated With Tysabri (NCT00752778) | University Hospital, Strasbourg, France | 2008-12-01 |
| Anti-Inflammatory Type II Monocyte Induction by Glatiramer Acetate (Copaxone) Treatment of Multiple Sclerosis (NCT00819195) | University of California, San Francisco | 2008-12-01 |
| Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX) (NCT00813709) | Merck KGaA, Darmstadt, Germany | 2008-12-01 |
| Oral Corticotherapy in Megadoses to Treat Multiple Sclerosis During Relapse (NCT00753792) | Germans Trias i Pujol Hospital | 2008-11-01 |
| An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period (NCT01112657) | Merck KGaA, Darmstadt, Germany | 2008-11-01 |
| A Pharmacokinetic (PK) Study of Natalizumab (Tysabri) at Steady State (NCT00744679) | Biogen | 2008-11-01 |
| The Efficacy of Botulinum Toxin in Disabling Multiple Sclerosis (MS) Tremor (NCT01018485) | Melbourne Health | 2008-10-01 |
| Comprehensive Multimodal Analysis of Neuroimmunological Diseases of the Central Nervous System (NCT00794352) | National Institute of Allergy and Infectious Diseases (NIAID) | 2008-10-01 |
| Duloxetine for Multiple Sclerosis Pain (NCT00755807) | Eli Lilly and Company | 2008-10-01 |
| Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis (NCT00678496) | University of Sheffield | 2008-10-01 |
| Immunogenicity and Safety of Subcutaneously-administered Avonex (Interferon Beta-1a) in Multiple Sclerosis (MS) Patients (NCT00784836) | Biogen | 2008-10-01 |
| Targeted Lower Extremity Joint Training (NCT00765544) | US Department of Veterans Affairs | 2008-09-01 |
| Evaluation of Risk Factors for Early Termination of Injection Treatment With Betaferon in Patients Suffering From Multiple Sclerosis (NCT01184833) | Bayer | 2008-09-01 |
| Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis (NCT00772525) | Sanofi | 2008-09-01 |
| Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis (NCT01074346) | Merck KGaA, Darmstadt, Germany | 2008-08-01 |
| An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis (NCT00751881) | Sanofi | 2008-08-01 |
| An Observational Study to Assess the Quality of Life of the Patients With Multiple Sclerosis and Their Caregivers (NCT01075737) | Merck KGaA, Darmstadt, Germany | 2008-08-01 |
| Correlation Between Multiple Sclerosis Functional Composite (MSFC) and Expanded Disability Status Scale (EDSS) in Patients With Multiple Sclerosis (MS) in Argentina (NCT01080014) | Merck KGaA, Darmstadt, Germany | 2008-08-01 |
| To Identify and Evaluate the Predictive Factors for Depression in Patients Diagnosed With Multiple Sclerosis (NCT01079975) | Merck KGaA, Darmstadt, Germany | 2008-08-01 |
| A Retrospective Study to Understand the Clinical Management of Subjects With Multiple Sclerosis at a Site in Taiwan Over the Last 10 Years (NCT01084798) | Merck KGaA, Darmstadt, Germany | 2008-08-01 |
| Progression of Cognitive and Physical Symptoms in Multiple Sclerosis (NCT00922831) | MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute | 2008-08-01 |
| Mesenchymal Stem Cells in Multiple Sclerosis (MSCIMS) (NCT00395200) | University of Cambridge | 2008-07-01 |
| 12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis. (NCT00735007) | EMD Serono | 2008-07-01 |
| Betaferon Use in Children and Adolescents With Multiple Sclerosis (NCT03577977) | Bayer | 2008-06-01 |
| Cognitive Testing for the Pain Quality Assessment Scale (PQAS) (NCT00715598) | University of Washington | 2008-06-01 |
| Lokomat Training Effects on MS Gait Abnormalities (NCT00766272) | US Department of Veterans Affairs | 2008-06-01 |
| A Randomized Exercise Trial for Wheelchair Users (NCT00866112) | University of Kansas | 2008-05-01 |
| Early Cognitive Impairment in Multiple Sclerosis (NCT01157728) | Assistance Publique - Hôpitaux de Paris | 2008-05-01 |
| Ofatumumab Dose-finding in Relapsing Remitting Multiple Sclerosis (RRMS) Patients (NCT00640328) | GlaxoSmithKline | 2008-05-01 |
| Far Infrared Irradiation for Managing and Treating Multiple Sclerosis (MS) (NCT00674934) | GAAD Medical Research Institute Inc. | 2008-05-01 |
| Effects of Aerobic and Isokinetic Exercise in Multiple Sclerosis (NCT03805061) | Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization | 2008-04-30 |
| BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) (NCT00605215) | Teva Branded Pharmaceutical Products R&D, Inc. | 2008-04-24 |
| Supported Treadmill Training for Progressive Multiple Sclerosis (NCT01339234) | Hicks, Audrey, Ph.D. | 2008-04-01 |
| An Extension Study of the Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing Multiple Sclerosis (NCT00670449) | Novartis | 2008-04-01 |
| Betaferon® Regulatory Post-Marketing Surveillance (NCT01414816) | Bayer | 2008-04-01 |
| Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis (NCT00629642) | Astellas Pharma Inc | 2008-03-14 |
| Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (NCT01339676) | University of Turku | 2008-03-01 |
| ATP Expression in Lymphocytes of MS Patients by Means of "ImmuKnow®" Assay. (NCT00618267) | Biogen | 2008-03-01 |
| Placebo vs. Linoleic Acid Controlled Assessment of Treatment Efficacy in MS (NCT00638196) | University of Rochester | 2008-03-01 |
| Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS) (NCT01432704) | University of Turku | 2008-03-01 |
| 12-week Safety Evaluation of Oral CS-0777 in Multiple Sclerosis Patients (NCT00616733) | Daiichi Sankyo | 2008-03-01 |
| Motor Imagery Practice in Neurological Rehabilitation (NCT00618085) | Nuffield Orthopaedic Centre NHS Trust | 2008-02-01 |
| Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis. (NCT00630383) | University of Nottingham | 2008-02-01 |
| Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple Sclerosis (NCT00622700) | Sanofi | 2008-02-01 |
| AT RISK FOR MS - Clinical Conversion of Female Monozygotic Twins Discordant for CIS/MS (NCT00617383) | The University of Texas Health Science Center, Houston | 2008-02-01 |
| Lokomat Treadmill Training Effects on MS Gait (NCT00835835) | Mount Sinai Rehabilitation Hospital | 2008-02-01 |
| Long-term Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis (NCT00662649) | Novartis | 2008-02-01 |
| Management of Pain in Persons With Multiple Sclerosis (NCT00621374) | University of Washington | 2008-02-01 |
| One Year Extension Study To Protocol C2/5/TZ:MS-05 (NCT00464958) | Teva GTC | 2008-01-01 |
| Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects (NCT00612872) | Institute for Neurodegenerative Disorders | 2008-01-01 |
| The Effects of Tysabri Treatment on Vaccination Response and Lymphocyte Subsets in Subjects With Relapsing Forms of Multiple Sclerosis (NCT00536120) | Biogen | 2008-01-01 |
| Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects (NCT00938366) | Merck KGaA, Darmstadt, Germany | 2008-01-01 |
| A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS) (NCT00681538) | Jazz Pharmaceuticals | 2008-01-01 |
| Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (NCT00509145) | Teva Branded Pharmaceutical Products R&D, Inc. | 2007-11-13 |
| A Multi-center, Multi-regional Observational Study to Test the Responsiveness of the Validated MusiQoL (Multiple Sclerosis International Quality of Life Questionnaire) Instrument to EDSS Status Changes in Any Form of Multiple Sclerosis (MS) in Patients With or Without Treatment (NCT00702065) | EMD Serono | 2007-11-01 |
| Teleconference Fatigue Management for People With Multiple Sclerosis (NCT00591721) | University of Illinois at Chicago | 2007-11-01 |
| Alfuzosin for Voiding Dysfunction in Multiple Sclerosis (MS) (NCT00688948) | Nova Scotia Health Authority | 2007-11-01 |
| Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study (NCT00937677) | University at Buffalo | 2007-11-01 |
| Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis (NCT00702468) | Jazz Pharmaceuticals | 2007-11-01 |
| Effects of Training on Central Auditory Function in Multiple Sclerosis (NCT01023074) | VA Office of Research and Development | 2007-10-01 |
| Long Term Safety of Teriflunomide When Added to Interferon-Beta or Glatiramer Acetate in Patients With Multiple Sclerosis (NCT00811395) | Sanofi | 2007-10-01 |
| A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis. (NCT00104143) | Hoffmann-La Roche | 2007-10-01 |
| Physical Disability in Patients Treated With Betaferon (NCT00873340) | Bayer | 2007-10-01 |
| Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study (NCT02523703) | University Hospital, Caen | 2007-09-10 |
| Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis (MS) (NCT00537082) | Novartis | 2007-09-01 |
| BENEFIT Extension Study (NCT00544037) | Bayer | 2007-09-01 |
| Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells (NCT00630721) | University of North Carolina, Chapel Hill | 2007-09-01 |
| Memantine Therapy for Multiple Sclerosis (NCT00638833) | Clinica Universidad de Navarra, Universidad de Navarra | 2007-09-01 |
| Comparison of 1.5T vs. 3T Protocols After Treatment With Glatiramer Acetate (GA) (NCT00937157) | University at Buffalo | 2007-09-01 |
| Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial (NCT00649792) | Acorda Therapeutics | 2007-08-01 |
| Evaluation of Natalizumab for thE Relief of MS Associated FatiGue (NCT00464074) | Biogen | 2007-08-01 |
| Study Of White Blood Cells In The Cerebrospinal Fluid And Blood Of Patients With Relapsing Forms Of Multiple Sclerosis (NCT00469378) | GlaxoSmithKline | 2007-07-01 |
| Allogeneic Stem Cell Transplantation for the Treatment of Multiple Sclerosis (NCT00497952) | Talaris Therapeutics Inc. | 2007-07-01 |
| Aspirin for Treatment of Multiple Sclerosis-Related Fatigue (NCT00467584) | Mayo Clinic | 2007-07-01 |
| IPX056 in Subjects With Established Spasticity Resulting From Multiple Sclerosis (NCT00488839) | Impax Laboratories, LLC | 2007-06-01 |
| Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis (NCT00480181) | University of Manitoba | 2007-06-01 |
| Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis (NCT00490906) | Nancy Hammond, MD | 2007-06-01 |
| Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With Betaseron (NCT00461396) | Bayer | 2007-05-01 |
| Phase II Study of Teriflunomide as Adjunctive Therapy to Interferon-beta in Subjects With Multiple Sclerosis (NCT00489489) | Sanofi | 2007-05-01 |
| Open, Multicentric, Prospective, Quality of Life Study in Multiple Sclerosis Patients (NCT00928967) | Bayer | 2007-05-01 |